The two FDA-approved drugs have demonstrated in clinical trials the capability to slow cognitive decline by several months, The Washington Post reported Oct. 8.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
2 Alzheimer's drugs show promise in slowing cognitive decline
